Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial.
Liu Q, Xu JY, Xu YH, Chen M, Deng LC, Wu JP, Zhou T, Zhang LQ, Tan J, Pu XX, Shang YL, Hua J, Li YQ, Cai W, Gu YL, Peng XC, Chan PC, Jabbour SK, Nam HS, Hua D.
Liu Q, et al. Among authors: chen m.
Transl Lung Cancer Res. 2022 May;11(5):832-844. doi: 10.21037/tlcr-22-313.
Transl Lung Cancer Res. 2022.
PMID: 35693282
Free PMC article.